PPBT today
$1.56+$0.06 (+4.00%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bullish
1 hourStrong Bullish
15 minStrong Bullish
5 minConsolidating
Daily trend turns up above $1.40
Key levels
Resistance$1.88
Resistance$1.61
Support$1.40
Support$1.25
Latest news & SEC filings
ProductPurple Biotech's IM1240 abstract accepted for oral presentation at EORTC-NCI-AACR Symposium
All PPBT news →About Purple Biotech
Purple Biotech is a drug developer focused on cancer treatments. Its pipeline includes an early-stage antibody platform known as CAPTN-3, along with two candidates in human testing, CM24 and NT219. The company is based in Israel and also operates in the United States, and none of its products have received marketing approval.
Based on the company's 20-F filed Mar 19, 2026.
Nasdaq · Healthcare
PURPLE BIOTECH LTD. (PPBT)
What Is the Price Target for PPBT?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is PPBT a Buy or Sell Right Now?
Thesis
- •Revenue growing 0.0% YoY with STRONG trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for PPBT.
Start Free Trial →Is PPBT Overvalued or Undervalued?
Valuation Verdict
N/A
Methods Used
N/A
Fair Value
$N/A
13
Moat Score
NONE
2/9
Piotroski Score
N/A
Altman Z-Score
What Is Smart Money Doing with PPBT?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →PPBT Growth Story
Revenue YoY
0.0%
3yr Revenue CAGR
115.4%
EPS Growth YoY
-99.46%
FCF Growth YoY
N/A%
Revenue Trend
STRONG
Dark Pool Trades for PPBT
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for PPBT, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 16:13:33 | $1.36 | 1,620 | $$2K | SELL |
| 16:04:40 | $1.36 | 1,620 | $$2K | SELL |
| 15:58:53 | $1.36 | 1,485 | $$2K | SELL |
| 20:22:35 | $1.34 | 1,492 | $$2K | BUY |
| 15:01:23 | $1.30 | 2,400 | $$3K | SELL |
5 dark pool trades shown · $$12K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for PURPLE BIOTECH LTD. (PPBT) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →PPBT — frequently asked questions
What is PPBT stock price today?
PURPLE BIOTECH LTD. (PPBT) is at $1.56, up 4.00% (+$0.06) at the Nov 12, 2026 close.
Why is PPBT stock moving today?
Latest PPBT news — Oct 29, 2026: Purple Biotech's IM1240 abstract accepted for oral presentation at EORTC-NCI-AACR Symposium
Did PPBT beat earnings?
PPBT last reported on Aug 7, 2026: EPS $1.07 vs -$0.98 expected — a beat of 209.2%.
What is PPBT's P/E ratio?
PPBT trades at a P/E of 44.4 vs a Healthcare average of 17.8.
Does PPBT pay a dividend?
PPBT does not currently pay a dividend.
What are PPBT support and resistance levels?
Support: $1.40, $1.25, $1.10. Resistance: $1.61, $1.88, $2.59.
What are insiders doing with PPBT?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on PPBT?
Oct 29, 2026: Purple Biotech's IM1240 abstract accepted for oral presentation at EORTC-NCI-AACR Symposium